Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Perspective Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CATX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders11298−14
Shares45.3M42.5M−2.79M (−6.2%)
Value$96.4M$146.3M+$49.9M (+51.8%)

New holders (10)

Institutions that held Perspective Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CATX in Q2 2025
InstitutionSharesValue% of portfolio
Schonfeld Strategic Advisors LLC143,332$493.1K0.00%
Mariner, LLC64,463$221.8K0.00%
Point72 Asset Management, L.P.60,021$206.5K0.00%
Axq Capital, LP20,480$70.5K0.02%
Los Angeles Capital Management LLC17,595$60.5K0.00%
Ground Swell Capital, LLC16,373$56.3K0.09%
The PNC Financial Services Group, Inc.1,833$6.30K0.00%
Raymond James Financial Inc1,802$6.20K0.00%
IFP Advisors, Inc0$1.38K0.00%
Jones Financial Companies LLLP140$5260.00%

Sold out (24)

Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.